AU1915100A - A method of genetic vector delivery - Google Patents
A method of genetic vector deliveryInfo
- Publication number
- AU1915100A AU1915100A AU19151/00A AU1915100A AU1915100A AU 1915100 A AU1915100 A AU 1915100A AU 19151/00 A AU19151/00 A AU 19151/00A AU 1915100 A AU1915100 A AU 1915100A AU 1915100 A AU1915100 A AU 1915100A
- Authority
- AU
- Australia
- Prior art keywords
- vector delivery
- genetic vector
- genetic
- delivery
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10888198P | 1998-11-17 | 1998-11-17 | |
US60108881 | 1998-11-17 | ||
PCT/US1999/027206 WO2000029033A2 (en) | 1998-11-17 | 1999-11-17 | A method of genetic vector delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1915100A true AU1915100A (en) | 2000-06-05 |
Family
ID=22324608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19151/00A Abandoned AU1915100A (en) | 1998-11-17 | 1999-11-17 | A method of genetic vector delivery |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1915100A (en) |
WO (1) | WO2000029033A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002539257A (en) | 1999-03-19 | 2002-11-19 | イーノス・ファーマシューティカルス・インコーポレーテッド | Increased drug bioavailability in the brain |
US20070190032A1 (en) * | 2006-02-13 | 2007-08-16 | Oncolytics Biotech Inc. | Use of Local Immune Suppression to Enhance Oncolytic Viral Therapy |
US8703136B2 (en) * | 2006-10-10 | 2014-04-22 | Regenesance B.V. | Complement inhibition for improved nerve regeneration |
US20230242887A1 (en) * | 2017-08-09 | 2023-08-03 | Ohio State Innovation Foundation | Oncolytic virus carrying e-cadherin and uses thereof |
EP3996744A4 (en) * | 2019-07-05 | 2023-07-12 | Apellis Pharmaceuticals, Inc. | Viral vector therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4866042A (en) * | 1987-11-18 | 1989-09-12 | Neuwelt Edward A | Method for the delivery of genetic material across the blood brain barrier |
EP0804076A4 (en) * | 1994-10-19 | 1998-10-21 | Genetic Therapy Inc | Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
-
1999
- 1999-11-17 AU AU19151/00A patent/AU1915100A/en not_active Abandoned
- 1999-11-17 WO PCT/US1999/027206 patent/WO2000029033A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000029033A3 (en) | 2000-10-05 |
WO2000029033A2 (en) | 2000-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5153296A (en) | Vectors for gene delivery | |
EP0921661A3 (en) | Routing method using a genetic algorithm | |
AU6386796A (en) | A lipidic vector for nucleic acid delivery | |
AU4024595A (en) | A genetic method of scheduling the delivery of non uniform inventory | |
AU4172599A (en) | A process for inhibiting expression of genes | |
AU5671696A (en) | Scytalidium catalase gene | |
AU2466299A (en) | A new human tumor-associated gene | |
AU3745599A (en) | Noncloning technique for expressing a gene of interest | |
AU6229098A (en) | Cancer-associated genes | |
AU9089398A (en) | New plant genes | |
AU4397797A (en) | Method of gene introduction | |
AU1915100A (en) | A method of genetic vector delivery | |
AU1106500A (en) | Alpha-2/delta gene | |
AUPP670698A0 (en) | A method of regulation | |
AU2208199A (en) | Cloning of a high growth gene | |
AUPO882497A0 (en) | A method of genotyping | |
AU6793598A (en) | Glycosylceramide-containing liposomes | |
AU1314201A (en) | A method of selective viewing | |
AU7372498A (en) | Entomopoxvirus-based gene delivery vector for vertebrates | |
AU7558998A (en) | Method for reinforcing | |
AUPP526898A0 (en) | A plant regulatory gene | |
GB9706469D0 (en) | Genetic method | |
AU1292301A (en) | Method for genetic manipulation | |
AUPP058797A0 (en) | Novel gene | |
AUPP470898A0 (en) | A regulatory gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |